Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Managing Brittle Diabetes with Intensive Monitoring and Individualized Insulin Regimens

Clinical Presentation and Underlying Causes

  • Diabetic autonomic neuropathy often manifests as resting tachycardia, exercise intolerance, orthostatic hypotension, gastroparesis, erectile dysfunction, and hypoglycemic unawareness, according to the American Diabetes Association 1

Management Strategies

  • The American Diabetes Association recommends implementing continuous glucose monitoring systems to identify patterns and prevent severe hypoglycemic episodes, with a strength of evidence rated as high 2
  • The American Diabetes Association suggests target glucose levels should be individualized based on hypoglycemia risk, with less stringent goals for those with hypoglycemia unawareness, based on moderate evidence 2
  • Engage in 150 minutes or more of moderate-to-vigorous intensity aerobic activity per week, spread over at least 3 days, as recommended by the American Diabetes Association, with a strength of evidence rated as strong 3
  • Include 2-3 sessions of resistance exercise on nonconsecutive days, as recommended by the American Diabetes Association, with a strength of evidence rated as moderate 3
  • Reduce sedentary behavior and interrupt prolonged sitting every 30 minutes, as recommended by the American Diabetes Association, with a strength of evidence rated as moderate 3

Addressing Autonomic Neuropathy

  • For gastroparesis, consider prokinetic agents and dietary modifications, as suggested by the American Diabetes Association, with a strength of evidence rated as moderate 1
  • Manage orthostatic hypotension with appropriate interventions, as recommended by the American Diabetes Association, with a strength of evidence rated as moderate 1
  • For painful diabetic neuropathy, consider medications such as tricyclic drugs, anticonvulsants, or duloxetine, as suggested by the American Diabetes Association, with a strength of evidence rated as moderate 1

Team-Based Care Approach

  • Utilize a collaborative, integrated team with expertise in diabetes, including physicians, nurse practitioners, nurses, dietitians, pharmacists, and mental health professionals, as recommended by the American Diabetes Association, with a strength of evidence rated as high 2

Prevention of Complications

  • Regularly screen for diabetes complications, including retinopathy, nephropathy, neuropathy, and cardiovascular disease, as recommended by the American Diabetes Association, with a strength of evidence rated as high 2
  • Consider screening patients with type 1 diabetes for autoimmune diseases, such as thyroid dysfunction or celiac disease, as suggested by the American Diabetes Association, with a strength of evidence rated as moderate 2
  • Implement strategies to prevent hypoglycemia, including education on recognition and treatment, as recommended by the American Diabetes Association, with a strength of evidence rated as high 2

Common Pitfalls to Avoid

  • Avoid therapeutic inertia, prioritize timely and appropriate intensification of therapy when targets aren't met, as recommended by the American Diabetes Association, with a strength of evidence rated as high 2
  • Avoid sole use of sliding-scale insulin in hospitalized patients, as recommended by the American Diabetes Association, with a strength of evidence rated as high 2
  • Don't aggressively pursue near-normal HbA1c levels in patients where such targets cannot be safely achieved, as recommended by the American Diabetes Association, with a strength of evidence rated as high 2

REFERENCES